Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9807659 | 1.00 | PAX8 (0.36) | PAX8USP2SLCO1B1ALDH1A1 | |
| SCHEMBL16429714 | 0.84 | PAX8 (0.35) | PAX8 | |
| SCHEMBL9617279 | 0.84 | PAX8 (0.38) | PAX8USP2ALDH1A1 | |
| SCHEMBL1182041 | 0.84 | PAX8 (0.38) | PAX8USP2ALDH1A1 | |
| SCHEMBL2223107 | 0.84 | PAX8 (0.38) | PAX8USP2ALDH1A1 | |
| SCHEMBL17748583 | 0.83 | PAX8 (0.36) | PAX8USP2SLCO1B1 | |
| SCHEMBL1788967 | 0.82 | PAX8 (0.41) | PAX8 | |
| SCHEMBL5355000 | 0.82 | PAX8 (0.37) | PAX8USP2SLCO1B1 | |
| SCHEMBL17748555 | 0.82 | PAX8 (0.34) | PAX8 | |
| SCHEMBL17767378 | 0.82 | PAX8 (0.41) | PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10857176-B2 | Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan | Oligo Médic Inc. (CA) | 2020-12-08 | — | — | US | claimed |
| US-20190247421-A1 | COMPOSITION COMPRISING POLYGLUCOSAMINE-GLYOXYLATE SOLUTIONS MIXED WITH HYALURONAN | OLIGO MEDIC INC. | 2019-08-15 | — | — | US | claimed |
| CN-103189435-B | Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions | OLIGO MEDIC INC. (CA) | 2016-02-17 | — | — | CN | claimed |
| EP-2609149-B1 | HIGHLY BIOCOMPATIBLE DUAL THERMOGELLING CHITOSAN/GLUCOSAMINE SALT COMPOSITIONS | OLIGO MEDIC INC (CA) | 2015-08-12 | — | — | EP | claimed |
| US-8784850-B2 | Highly biocompatible dual thermogelling chitosan/glucosamine salt composition | OLIGO MEDIC INC (CA) | 2014-07-22 | — | — | US | claimed |
| US-20130266549-A1 | HIGHLY BIOCOMPATIBLE DUAL THERMOGELLING CHITOSAN/GLUCOSAMINE SALT COMPOSITION | OLIGO MEDIC INC (CA) | 2013-10-10 | — | — | US | claimed |
| US-8506972-B2 | Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions | OLIGO MEDIC INC (CA) | 2013-08-13 | — | — | US | claimed |
| EP-2609149-A1 | HIGHLY BIOCOMPATIBLE DUAL THERMOGELLING CHITOSAN/GLUCOSAMINE SALT COMPOSITIONS | Oligo Medic Inc. (CA) | 2013-07-03 | — | — | EP | claimed |
| CN-103189435-A | Highly biocompatible dual thermogelling chitosan/glucosamine salt compositions | OLIGO MEDIC INC | 2013-07-03 | — | — | CN | claimed |
| US-20120052012-A1 | HIGHLY BIOCOMPATIBLE DUAL THERMOGELLING CHITOSAN/GLUCOSAMINE SALT COMPOSITIONS | OLIGO MEDIC INC. (CA) | 2012-03-01 | — | — | US | claimed |
| WO-2012024785-A1 | HIGHLY BIOCOMPATIBLE DUAL THERMOGELLING CHITOSAN/GLUCOSAMINE SALT COMPOSITIONS | OLIGO MEDIC INC. (CA) | 2012-03-01 | — | — | WO | claimed |
| EP-0236771-B1 | AMINO SUGAR CARBONATING AGENTS AND THEIR PREPARATION | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1991-05-08 | — | — | EP | claimed |
| US-4766209-A | REACTING BICARBONATE IONS WITH EITHER GALACTOSAMINE OR GLUCOSAMINE | NESTEC S. A. (CH) | 1988-08-23 | — | — | US | claimed |
| EP-0236771-A2 | Amino sugar carbonating agents and their preparation | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1987-09-16 | — | — | EP | claimed |
| US-10857176-B2 | Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan | Oligo Médic Inc. (CA) | 2020-12-08 | — | — | US | disclosed |
| US-20190247421-A1 | COMPOSITION COMPRISING POLYGLUCOSAMINE-GLYOXYLATE SOLUTIONS MIXED WITH HYALURONAN | OLIGO MEDIC INC. | 2019-08-15 | — | — | US | disclosed |
| US-20170216341-A1 | COMPOSITION COMPRISING POLYGLUCOSAMINE-GLYOXYLATE SOLUTIONS MIXED WITH HYALURONAN | OLIGO MÉDIC INC (CA) | 2017-08-03 | — | — | US | disclosed |
| US-4766209-A | REACTING BICARBONATE IONS WITH EITHER GALACTOSAMINE OR GLUCOSAMINE | NESTEC S. A. (CH) | 1988-08-23 | — | — | US | disclosed |
| EP-0236771-A2 | Amino sugar carbonating agents and their preparation | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1987-09-16 | — | — | EP | disclosed |
| EP-0236771-A2 | Amino sugar carbonating agents and their preparation | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 1987-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10857176-B2 | Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan | CD44, IDUA, FUT6 | PAX8 3547/4885USP2 628/4885SLCO1B1 1828/4885 |
| US-20170216341-A1 | COMPOSITION COMPRISING POLYGLUCOSAMINE-GLYOXYLATE SOLUTIONS MIXED WITH HYALURONAN | CD44, IDUA, FUT6 | PAX8 3547/4885USP2 628/4885SLCO1B1 1828/4885 |
| US-20190247421-A1 | COMPOSITION COMPRISING POLYGLUCOSAMINE-GLYOXYLATE SOLUTIONS MIXED WITH HYALURONAN | CD44, IDUA, FUT6 | PAX8 3547/4885USP2 628/4885SLCO1B1 1828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.